蛋白名稱:FGF10人重組蛋白，10573-HNAE

蛋白構(gòu)建:A DNA sequence encoding the mature form of human FGF10 (NP_004456.1) (Gln38-Ser208) was expressed with an N-terminal Met.

表達宿主:E. coli

蛋白純度:≥ 95 % as determined by SDS-PAGE. ≥ 95 % as determined by SEC-HPLC.

蛋白活性:

1.Measured in a cell proliferation assay using BaF3 mouse pro-B cells transfected with human FGFR2b. The * for this effect is typically 3-30 ng/mL.

2.Human lung cancer organoids were cultured with FGF2(Cat#10014-HNAE), FGF4(Cat#16043-HNAE), FGF7(Cat#10210-H07E), EGF(Cat#50482-MNCH), FGF10(Cat#10573-HNAE), NOG(Cat#50688-M02H), RSPO1(Cat#11083-HNAS). (Routinely tested). Data provided by D1 Medical Technology.

3.Human lung organoids were cultured with FGF2(Cat#10014-HNAE), FGF4(Cat#16043-HNAE), FGF7(Cat#10210-H07E), EGF(Cat#50482-MNCH), FGF10(Cat#10573-HNAE), NOG(Cat#50688-M02H), RSPO1(Cat#11083-HNAS). (Routinely tested). Data provided by D1 Medical Technology.

4.Human cholangiocarcinomas organoids were cultured with FGF2(Cat#10014-HNAE), HGF(Cat#10463-HNAS), FGF7(Cat#10210-H07E), EGF(Cat#50482-MNCH), FGF10(Cat#10573-HNAE), NOG(Cat#50688-M02H), RSPO1(Cat#11083-HNAS). (Routinely tested). Data provided by D1 Medical Technology.

5.Human liver cancer organoids were cultured with FGF2(Cat#10014-HNAE), HGF(Cat#10463-HNAS), FGF7(Cat#10210-H07E), EGF(Cat#50482-MNCH), FGF10(Cat#10573-HNAE), TGFB1(Cat#10804-HNAC), NOG(Cat#50688-M02H), RSPO1(Cat#11083-HNAS). (Routinely tested). Data provided by D1 Medical Technology.

6.Human kidney cancer organoids were cultured with FGF2(Cat#10014-HNAE), FGF7(Cat#10210-H07E), EGF(Cat#50482-MNCH), FGF10(Cat#10573-HNAE), NOG(Cat#50688-M02H), RSPO1(Cat#11083-HNAS). (Routinely tested). Data provided by D1 Medical Technology.

7.Human kidney organoids were cultured with FGF7(Cat#10210-H07E), EGF(Cat#50482-MNCH), FGF10(Cat#10573-HNAE), NOG(Cat#50688-M02H), RSPO1(Cat#11083-HNAS), HGF(Cat#10463-HNAS), FGF4(Cat#16043-HNAE). (Routinely tested). Data provided by D1 Medical Technology.

8.Human gastric cancer organoids were cultured with EGF(Cat#50482-MNCH), FGF10(Cat#10573-HNAE), NOG(Cat#50688-M02H), RSPO1(Cat#11083-HNAS). (Routinely tested). Data provided by D1 Medical Technology.

9.Human stomach organoids organoids were cultured with EGF(Cat#50482-MNCH), FGF10(Cat#10573-HNAE), NOG(Cat#50688-M02H), RSPO1(Cat#11083-HNAS). (Routinely tested). Data provided by D1 Medical Technology.

10.Human small intestinal organoids were cultured with IL22(13059-HNAE), FGF10(10573-HNAE), EGF(50482-MNCH), NOG(50688-M02H). (Routinely tested). Data provided by D1 Medical Technology.

蛋白內(nèi)毒素:< 5 EU per mg of the protein.

預測N端:Met

蛋白分子量:The recombinant human FGF10 consists of 172 amino acids and has a predicted molecular mass of 19.46 kDa as estimated in SDS-PAGE under reducing conditions.

蛋白NP號:NP_004456.1

蛋白氨基酸序列:Gln38-Ser208

蛋白標簽:Native

歡迎去義翹神州網(wǎng)查看FGF10人重組蛋白，10573-HNAE詳細信息。網(wǎng)址：https://cn.sinobiological.com/recombinant-proteins/human-fgf10-10573-hnae

義翹神州研發(fā)團隊擁有多年的重組蛋白研發(fā)經(jīng)驗。多年來，我們的團隊已開發(fā)出超過9300余種重組蛋白，涵蓋免疫檢查點、抗體藥物靶點、CAR-T細胞治療靶點、Fc受體、流感病毒蛋白以及細胞因子等熱門研究領(lǐng)域。義翹神州重組蛋白具有高純度、高生物活性和低內(nèi)毒素水平等特性，可為生物藥靶點發(fā)現(xiàn)、蛋白質(zhì)結(jié)構(gòu)和功能分析、細胞療法和重組酶酶學性質(zhì)等科學研究提供支持。

義翹神州利用蛋白表達平臺，提供重組蛋白生產(chǎn)"一站式"技術(shù)服務(wù)。我們的服務(wù)包括蛋白基因合成、蛋白質(zhì)密碼子優(yōu)化、蛋白質(zhì)表達載體設(shè)計、大規(guī)模細胞培養(yǎng)和發(fā)酵、蛋白純化和蛋白質(zhì)量控制檢測。我們在蛋白表達和大規(guī)模生產(chǎn)方面有著顯著的成本節(jié)約和速度優(yōu)勢，同時在設(shè)計各種類型的重組蛋白純化項目（帶或不帶純化標簽）方面也擁有著豐富的經(jīng)驗和專業(yè)技術(shù)。 義翹神州擁有經(jīng)驗豐富的技術(shù)團隊，每年可研發(fā)生產(chǎn)1,000+種重組蛋白開發(fā)和大規(guī)模生產(chǎn)項目。我們有能力進行快速的蛋白質(zhì)表達和純化工藝開發(fā)，根據(jù)需求進行工藝放大研究，并且可滿足高通量和大規(guī)模批量生產(chǎn)蛋白質(zhì)的要求。 我們致力于成為重組蛋白和單克隆抗體大規(guī)模生產(chǎn)的實驗室，為藥物研發(fā)企業(yè)和生命科學機構(gòu)提供高水平的技術(shù)服務(wù)。

歡迎小伙伴來咨詢哦!  請注明來源、姓名，單位！

關(guān)注義翹神州或添加微信“sinobio2023"進行聯(lián)系！